Department of Respiratory Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
Respiration. 2017;94(2):224-231. doi: 10.1159/000477258. Epub 2017 Jun 22.
Pneumothorax after bronchoscopic lung volume reduction using one-way endobronchial valves (EBVs) in patients with advanced emphysema occurs in approximately 20% of patients. It is not well known which factors predict the development of pneumothorax.
To assess whether pleural adhesions on pretreatment high-resolution computed tomography (HRCT) scans are associated with pneumothorax occurrence after EBV treatment.
HRCT scan analyses were performed on all patients who received EBV treatment in a randomized controlled trial. Three blinded readers scored adhesions by number and by measuring the longest axis of each pleural adhesion in the treated lung. The Pleural Adhesion Score (PAS) was calculated by adding 1 point for each small pleural lesion (<1 mm), 5 points for each medium-sized lesion (1-5 mm), and 10 points for each large lesion (>5 mm).
The HRCT scans of 64 treated patients were assessed, of whom 14 developed pneumothorax. Patients who developed pneumothorax had a higher median number of pleural adhesions, 2.7 (IQR 1.9-4) compared to 1.7 (1-2.7) adhesions in the group without pneumothorax (p < 0.01). The PAS in the group with pneumothorax was higher compared to that in the group without: 14.3 (12.4-24.1) versus 6.7 (3.7-11.2) (p < 0.01). A threshold PAS of ≥12 was associated with a higher risk of pneumothorax (OR 13.0, 95% CI 3.1-54.9). A score <12 did not rule out the occurrence of pneumothorax.
A higher number of pleural adhesions on HRCT with a subsequent higher PAS in the treated lung is associated with a higher occurrence of pneumothorax after EBV treatment.
在接受单向支气管内瓣膜(EBV)治疗的晚期肺气肿患者中,约 20%的患者会出现气胸。目前尚不清楚哪些因素可预测气胸的发生。
评估治疗前高分辨率计算机断层扫描(HRCT)上的胸膜粘连是否与 EBV 治疗后气胸的发生有关。
对所有接受 EBV 治疗的患者进行 HRCT 扫描分析。三位盲法读者通过数量和测量治疗肺中每个胸膜粘连的最长轴对粘连进行评分。胸膜粘连评分(PAS)通过对每个小胸膜病变(<1mm)加 1 分,每个中等大小病变(1-5mm)加 5 分,每个大病变(>5mm)加 10 分来计算。
共评估了 64 例接受治疗的患者的 HRCT 扫描结果,其中 14 例发生气胸。发生气胸的患者胸膜粘连中位数更高,为 2.7(IQR 1.9-4),而无气胸组为 1.7(1-2.7)(p<0.01)。气胸组的 PAS 高于无气胸组:14.3(12.4-24.1)比 6.7(3.7-11.2)(p<0.01)。PAS≥12 与气胸风险增加相关(OR 13.0,95%CI 3.1-54.9)。评分<12 并不能排除气胸的发生。
治疗肺中 HRCT 上的胸膜粘连数量较多,随后的 PAS 较高与 EBV 治疗后气胸的发生频率较高相关。